A Win For NeuroSense Therapeutics Ltd.
Fri, Sep 04, 2026 at 07:37 PM
NeuroSense Therapeutics Ltd. (NRSN:NASDAQ) rocketted at $0.51, a gain of 27.2%. On Fri, Sep 04, 2026, NRSN:NASDAQ touched a New 2-Week High of $0.51. The stock got featured on our News Catalysts scanner on Mon, Aug 31, 2026 at 01:01 PM in the 'MISCELLANEOUS' category. From Fri, Aug 21, 2026, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Mon, Jun 29, 2026 at $0.95 with a volume of 1M+.
About NeuroSense Therapeutics Ltd. (NRSN:NASDAQ)
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these...
Top 10 Gainers:
- Vestand Inc Cl A (New) (VSTD:NASDAQ), 333.33%
- Hempacco Co., Inc. (HPCO:NASDAQ), 100%
- Immuron Limited (IMRN:NASDAQ), 62.16%
- CDT Environmental Technology Investment Holdings Limited (CDTG:NASDAQ), 46.72%
- American Outdoor Brands, Inc. (AOUT:NASDAQ), 44.66%
- Onconetix, Inc. (ONCO:NASDAQ), 38.02%
- NeuroSense Therapeutics Ltd. (NRSN:NASDAQ), 27.19%
- GRI Bio, Inc. (GRI:NASDAQ), 25.76%
- Mannatech, Incorporated (MTEX:NASDAQ), 23.46%
- Nature Wood Group Limited (NWGL:NASDAQ), 23.3%